Abstract
This report describes a delayed recognition of mpox in a patient admitted to an inpatient psychiatry unit, resulting in potential exposures to staff and patients. We detail the investigation and risk mitigation efforts and emphasize the importance of prompt identification and isolation in congregate healthcare settings to prevent transmission.